Promakhos Therapeutics
PrivateLast Round
Grant
May 6, 2026
Est. Valuation
$1.79M
Total Funding Raised
$794,365
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Promakhos Therapeutics is a biotechnology company developing advanced, targeted, immune-modulating therapies for autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promakhos Therapeutics Comparables
Compare Promakhos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piton Therapeutics | 83% | |
| Ensho Therapeutics | 81% | |
| Eli Lilly and Company | 72% | |
Promakhos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2026 | ||||
| Grant | Feb 19, 2024 | ||||
| Grant | Jan 24, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Accelerator | Oct 31, 2021 | ||||
Accelerator | Jul 15, 2021 |
Key People
Founding team and executive leadership
Promakhos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Accelerator |
| Harvard Innovation Launch Lab | Seed |
| Harvard Innovation Labs | Accelerator, Seed |
| Metaplanet Holdings | Accelerator |
| ZAKA VC | Accelerator |
| Massachusetts Life Sciences Center | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
$75K grant from Harvard President's Innovation Challenge.
- Feb 19, 2024
$100K grant from Massachusetts Life Sciences Center
Promakhos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Promakhos Therapeutics's valuation, stock price, and market status.